(Q57758918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Elizabeth Drummond

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Trevor Leong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Michael Michael

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Cuong P Duong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Robert J S Thomas

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

21 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

number of pages

9

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

770-778

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-005-0040-z

18 January 2020

exact match

0 references

cites work

Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy

1 reference

12 December 2020

Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

12 December 2020

Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer

1 reference

12 December 2020

The changing epidemiology of esophageal cancer

1 reference

12 December 2020

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

1 reference

12 December 2020

Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy

1 reference

12 December 2020

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging

1 reference

12 December 2020

Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma

1 reference

12 December 2020

Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma

1 reference

12 December 2020

(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer

1 reference

12 December 2020

The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study.

1 reference

12 December 2020

Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.

1 reference

12 December 2020

Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer

1 reference

12 December 2020

Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy

1 reference

12 December 2020

Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer

1 reference

12 December 2020

Impact of positron emission tomography on the management of patients with small-cell lung cancer: preliminary experience

1 reference

12 December 2020

Surgical therapy of oesophageal carcinoma

1 reference

12 December 2020

Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation

1 reference

12 December 2020

Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer

1 reference

12 December 2020

Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus

1 reference

12 December 2020

Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials

1 reference

12 December 2020

Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography

1 reference

12 December 2020

Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy

1 reference

12 December 2020

Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer

1 reference

12 December 2020

Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer

1 reference

12 December 2020

Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer

1 reference

12 December 2020

2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma

1 reference

12 December 2020

Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma

1 reference

12 December 2020

Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.

1 reference

12 December 2020

Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma

1 reference

12 December 2020

The use of chemoradiotherapy in oesophageal cancer

1 reference

12 December 2020

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography

1 reference

12 December 2020

Improvement in staging of esophageal cancer with the addition of positron emission tomography

1 reference

12 December 2020

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment

1 reference

12 December 2020

Adding structure to function

1 reference

12 December 2020

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer

1 reference

12 December 2020

Image registration: an essential tool for nuclear medicine

1 reference

12 December 2020

10.1007/S00259-005-0040-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550384%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference